The diabetes medication Avandia, sold by the British company GlaxoSmithKline PLC, is linked to heart attacks and heart failure. Avandia, rosiglitazone maleate, was linked to 304 deaths during the third quarter of 2009, according to reports. Some officials in the Food and Drug Administration (FDA) have recommended taking action to protect the public from this potentially dangerous drug.
"Rosiglitazone should be removed from the market," concludes one confidential report written by FDA doctors and quoted in The New York Times.
Researchers have reported a 64 percent increased risk of dying from cardiovascular causes while taking the drug. The studies concluded that there were 86 heart attacks and 39 deaths among the 15,560 Avandia patients, compared with 72 heart attacks and 22 deaths among the 12,283 patients not taking Avandia.
The risks associated with Avandia include the following:
Avandia is also linked to reports of a swelling of the retina that can interfere with vision.
If you or a loved one has suffered a catastrophic injury or death from a cardiac event after using Avandia, contact an experienced attorney at Metzger Wickersham. We can help you decide how to proceed with an Avandia lawsuit. At Metzger Wickersham, our personal injury attorneys are committed to helping clients successfully resolve their claims.
Remember, your initial consultation is free, and you don't pay us unless you win.
